Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports (Q34854165)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports |
scientific article |
Statements
1 reference
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports (English)
1 reference
A M Evens
1 reference
B D Jovanovic
1 reference
Y-C Su
1 reference
D W Raisch
1 reference
D Ganger
1 reference
S M Belknap
1 reference
M-S Dai
1 reference
B-C C Chiu
1 reference
B Fintel
1 reference
Y Cheng
1 reference
S-S Chuang
1 reference
M-Y Lee
1 reference
T-Y Chen
1 reference
S-F Lin
1 reference
C-Y Kuo
1 reference
29 November 2010
1 reference
1 reference
22
1 reference
5
1 reference
1170-1180
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference